Disclaimer

This information is provided for educational purposes and should not be considered medical advice. It is intended to supplement, not replace, the judgment of a qualified healthcare professional. Clinical decisions must always be made based on the specific circumstances of each patient, considering their unique clinical presentation, medical history, and the most current evidence and local guidelines. Always consult with a physician or other qualified healthcare provider for any questions about a medical condition or before taking any medication or making any changes to your healthcare.

---

Complex Febrile Seizures

Overview

• Definition: Complex febrile seizures are a subtype of febrile seizures characterized by one or more of the following features:
  1. Focal features: The seizure exhibits localized motor activity (e.g., jerking of one limb, head deviation, eye deviation) rather than being generalized.
  2. Prolonged duration: The seizure lasts for longer than 15 minutes.
  3. Multiple seizures within 24 hours: The child experiences more than one febrile seizure episode within a 24-hour period.
• Epidemiology:
  • Febrile seizures affect approximately 2% to 5% of children, making them the most common type of seizure in childhood.
  • Complex febrile seizures account for 10% to 35% of all febrile seizures.
  • The peak incidence for febrile seizures (both simple and complex) is between 6 months and 5 years of age, with the highest frequency around 18 months.
  • There is a slight male predominance.
• Classification: Complex febrile seizures are a distinct classification within the spectrum of febrile seizures, differentiating them from "simple febrile seizures" which are generalized, last less than 15 minutes, and do not recur within 24 hours. They are not considered a form of epilepsy unless the child subsequently develops afebrile seizures.

Pathophysiology

• Mechanism: The exact mechanism of febrile seizures, including complex forms, is not fully understood but is believed to involve a combination of genetic predisposition and the effect of fever on the immature developing brain.
  • Brain Immaturity: The developing brain in young children has a lower seizure threshold compared to older children and adults, making it more susceptible to seizure activity in response to various stimuli, including fever.
  • Fever and Cytokines: Rapid rise in body temperature and the presence of inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α) during an infection are thought to modulate neuronal excitability. These cytokines can alter ion channel function, neurotransmitter release, and synaptic plasticity.
  • Genetic Susceptibility: Genetic factors play a significant role. Mutations or polymorphisms in genes encoding for ion channels (e.g., sodium, potassium, GABA-A receptor subunits) or genes involved in inflammation have been implicated. Family history of febrile seizures or epilepsy increases risk.
• Risk Factors:
  • Age: 6 months to 5 years (peak 12-18 months).
  • Family History: First-degree relative with a history of febrile seizures or epilepsy.
  • Fever Characteristics: High temperature (>39°C or 102.2°F), rapid rise in temperature, or short duration of fever prior to seizure onset.
  • Viral Infections: Common triggers include infections with Human Herpesvirus 6 (HHV-6, leading to roseola infantum), influenza, adenoviruses, and respiratory syncytial virus (RSV).
  • Developmental Delay: Pre-existing neurological abnormalities or developmental delay significantly increases the risk of complex febrile seizures and subsequent epilepsy.
  • Neonatal Care: History of neonatal care admission for >28 days.
  • Vaccinations: Rarely, certain vaccinations (e.g., MMR, DTaP) can trigger fever and subsequent febrile seizures. This is a rare and self-limited phenomenon.
  • Iron Deficiency Anemia: Some studies suggest a correlation, though not definitively causative.
• Protective Factors: No specific protective factors have been definitively identified to prevent febrile seizures. Maintaining a healthy lifestyle, age progression, and avoiding infectious illnesses generally reduce the risk of seizure triggers.

Clinical Presentation

Signs and Symptoms

• Cardinal Features: The defining characteristics that differentiate complex febrile seizures from simple ones:
  • Focal onset/features: Seizure activity starts or is predominantly localized to one side of the body or a specific limb (e.g., unilateral clonic jerking, head/eye deviation). Post-ictal Todd's paresis (temporary weakness on one side) may be observed.
  • Prolonged duration: The seizure lasts for more than 15 minutes. This includes episodes of febrile status epilepticus (seizure lasting >30 minutes or recurrent seizures without full recovery between episodes).
  • Multiple occurrences: More than one febrile seizure within a 24-hour period.
• Early Signs:
  • Sudden onset of fever, often rapidly rising.
  • Irritability, malaise, or other non-specific signs of an underlying infection.
  • Loss of consciousness followed by tonic-clonic movements, but with the presence of focal features.
• Advanced Signs:
  • Post-ictal drowsiness, confusion, or irritability lasting for minutes to hours.
  • Possible transient focal neurological deficits (Todd's paresis) following a focal seizure, which should resolve completely within hours (typically < 24 hours).
  • Signs of underlying severe infection if not managed.
• Atypical Presentations:
  • Seizure occurring with minimal or no fever (<38°C or 100.4°F). This raises suspicion for afebrile seizures or other underlying pathology.
  • Seizure in a child with a known afebrile seizure disorder.
  • Seizure accompanied by persistent neurological deficits beyond the expected post-ictal period, suggesting a structural lesion or acute neurological insult.

Physical Examination

• Inspection:
  • General appearance: Evaluate for signs of distress, level of consciousness, signs of dehydration.
  • Skin: Check for rash (e.g., petechiae, purpura suggesting sepsis/meningitis; maculopapular rash suggesting viral exanthem like roseola).
  • Head/Face: Look for signs of trauma, nuchal rigidity (neck stiffness) which might indicate meningitis, fontanelle fullness or bulging in infants.
  • Breath: Assess respiratory effort and presence of stridor, wheezing.
  • Motor Activity: Observe for any lingering focal weakness or asymmetry in movement, which would suggest Todd's paresis or an underlying neurological issue.
• Palpation:
  • Fontanelle: In infants, check for bulging or depressed fontanelle.
  • Lymph nodes: Palpate cervical and generalized lymphadenopathy as a sign of infection.
  • Abdomen: Palpate for tenderness or organomegaly (less common in febrile seizures).
• Special Tests:
  • Neurological Examination:
    • Cranial Nerves: Assess pupillary response, extraocular movements, facial symmetry.
    • Motor/Sensory: Evaluate muscle tone, strength, reflexes symmetrically. Look for persistent asymmetry or weakness.
    • Cerebellar: Assess coordination (if appropriate for age and patient state).
  • Meningeal Signs:
    • Nuchal rigidity: Inability to flex the neck forward due to rigidity of the neck muscles.
    • Brudzinski's sign: Passive flexion of the neck causes spontaneous flexion of the hips and knees.
    • Kernig's sign: Inability to extend the leg fully when the hip is flexed to 90 degrees due to hamstring spasm.
    • Note: These signs may be absent or unreliable in very young infants.

Diagnostic Approach

History Taking

• Key Questions:
  • Seizure characteristics:
    • Description of movements: Generalized vs. focal (e.g., jerking of one limb, eye deviation).
    • Duration: Exact or estimated time seizure lasted (>15 minutes?).
    • Number of episodes: Was this the first, or have there been multiple seizures in the last 24 hours?
    • Post-ictal state: How long did it take for the child to return to baseline? Any lingering weakness or altered mental status?
  • Fever characteristics:
    • Highest temperature recorded, route of measurement.
    • Duration of fever before seizure, rapidity of temperature rise.
    • Any antipyretics given and their effect.
  • Associated symptoms: Any signs of specific infection (cough, rhinorrhea, vomiting, diarrhea, ear pain, rash, decreased urine output, decreased intake).
  • Past medical history:
    • History of previous febrile seizures (simple or complex), age at first seizure.
    • Developmental milestones (any delays?).
    • Previous neurological problems, head trauma, hospitalizations.
    • Immunization status (especially for Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae (Pneumococcal Conjugate Vaccine, PCV)).
  • Family history: Febrile seizures, epilepsy, or other neurological disorders in first-degree relatives.
  • Medications: Any current medications.
• Red Flags:
  • Age < 6 months: Higher risk of serious underlying infection (e.g., bacterial meningitis) and often have subtle signs.
  • Persistent altered mental status: Beyond the expected post-ictal period.
  • Persistent focal neurological deficit: Beyond the expected post-ictal period (e.g., Todd's paresis that doesn't resolve within hours).
  • Signs of increased intracranial pressure: Bulging fontanelle (infants), persistent vomiting, severe headache, papilledema (rarely seen acutely).
  • Signs of serious bacterial infection: Petechial rash, severe lethargy, inconsolability, poor perfusion.
  • Incomplete immunization status: Especially for Hib and PCV.
  • Recent antibiotic use: May mask signs of bacterial meningitis.
  • Immunocompromised state.

Laboratory Tests

• First-Line:
  • Blood tests (CBC, electrolytes, glucose): Generally not routinely recommended for complex febrile seizures unless specific clinical indications exist (e.g., suspicion of sepsis, poor intake, prolonged seizure causing metabolic derangements, severe dehydration).
  • Urine analysis/culture: Consider if signs of urinary tract infection are present or for fever of unknown origin, especially in infants.
• Confirmatory (when indicated):
  • Lumbar Puncture (LP): This is the most crucial diagnostic test when central nervous system (CNS) infection is suspected.
    • Strong indications:
      • Any child with meningeal signs (nuchal rigidity, Kernig's, Brudzinski's).
      • Infants < 12 months of age: Always consider LP due to the subtle or absent signs of meningitis in this age group. The American Academy of Pediatrics (AAP) states LP "should be strongly considered."
      • Children 12-18 months of age: Consider LP, especially if immunization status is incomplete or if antibiotics were given prior to presentation (which can mask meningitis signs).
      • Any age child with signs of increased intracranial pressure or persistent alteration of consciousness not explained by post-ictal state.
      • Patient on antibiotics prior to seizure (risk of partially treated meningitis).
    • Generally not recommended routinely: For complex febrile seizures without any of the above indications. The yield for meningitis in a well-appearing child with complex febrile seizure who rapidly recovers is low.
• Monitoring:
  • Serial neurological exams to assess for resolution of post-ictal state and any focal deficits.
  • Vital signs (temperature, heart rate, respiratory rate, blood pressure).

Imaging

• Recommended: Routine neuroimaging (CT or MRI of the brain) is NOT recommended for the evaluation of complex febrile seizures.
  • Indications for imaging:
    • Persistent focal neurological deficit beyond the expected post-ictal period (e.g., >24 hours).
    • Signs of increased intracranial pressure (e.g., bulging fontanelle, papilledema, persistent vomiting).
    • Evidence of head trauma.
    • Macrocephaly or other abnormal head circumference.
    • History of underlying neurodevelopmental abnormality or suspicious prior neurological events.
    • Clinical suspicion of a structural brain lesion or acute neurological event (e.g., stroke, intracranial hemorrhage).
• Advanced:
  • MRI with contrast: May be considered if there is strong suspicion of a subtle cortical malformation, prior brain injury (e.g., hippocampal sclerosis after prolonged febrile status epilepticus), or inflammatory process if initial CT is non-contributory and clinical suspicion remains high. This is typically not an acute emergency room study for complex febrile seizures.
  • EEG (Electroencephalogram):
    • Routine EEG is NOT recommended after a complex febrile seizure. It does not predict the recurrence of febrile seizures or the development of subsequent epilepsy in children with otherwise normal development and a resolution of their clinical status.
    • Indications for EEG:
      • Persistent atypical features (e.g., prolonged post-ictal state, persistent neurological deficits).
      • Concern for underlying afebrile seizure disorder.
      • Significant developmental regression or abnormalities.
      • Multiple complex febrile seizures that raise strong suspicion for underlying epilepsy.

Management

Acute Management

• Immediate (Pre-hospital/First 5 minutes):
  • Airway, Breathing, Circulation (ABCs): Ensure patent airway (place child in recovery position, clear any secretions). Monitor respiratory effort and color.
  • Safety: Protect the child from injury during the seizure; loosen tight clothing. Do not restrain or put anything in the mouth.
  • Time the seizure: Note the onset and duration of the seizure.
• Stabilization (If seizure continues > 5 minutes):
  • Administer a benzodiazepine:
    • Rectal Diazepam: 0.5 mg/kg (max 20 mg/dose).
    • Intranasal Midazolam: 0.2-0.3 mg/kg (max 10 mg/dose).
    • Buccal Midazolam: 0.2-0.3 mg/kg (max 10 mg/dose).
    • Intravenous (IV) Lorazepam: 0.1 mg/kg (max 4 mg/dose, infuse over 2-5 minutes). This is preferred if IV access is established.
  • Monitor vital signs: Heart rate, respiratory rate, oxygen saturation, blood pressure, temperature.
  • Fever control: Administer antipyretics (e.g., acetaminophen 15 mg/kg PO/PR or ibuprofen 10 mg/kg PO). Physical cooling (e.g., cool compresses) is less effective for core temperature but can be used as comfort measure.
• Emergency (If seizure continues > 15-30 minutes despite initial benzodiazepine):
  • Secure IV access.
  • Consider second-line anticonvulsants for status epilepticus:
    • IV Fosphenytoin: 15-20 mg PE (phenytoin equivalents)/kg loading dose (infuse at 1.5-3 mg PE/kg/min).
    • IV Levetiracetam: 20-60 mg/kg loading dose.
    • IV Valproic Acid: 20-40 mg/kg loading dose.
  • Consult Neurology/Critical Care: If the seizure is prolonged or difficult to control.
  • Investigate underlying cause: While managing the seizure, pursue diagnostic workup for meningitis/encephalitis as described above (LP, labs, imaging as indicated).

Chronic Management

• Pharmacological:
  • Routine prophylactic antiepileptic drugs (AEDs) are NOT recommended for preventing future febrile seizures or epilepsy due to the benign nature of most febrile seizures and the significant side effects of chronic AED therapy (e.g., cognitive impairment, behavioral changes, idiosyncratic reactions).
  • Intermittent oral diazepam: May be considered for a small subset of children with very frequent or distressing recurrences. However, it only reduces recurrence of febrile seizures, does not prevent epilepsy, and can cause sedation, ataxia, or behavioral changes. Not widely used due to side effect profile.
• Non-pharmacological:
  • Parental Education and Reassurance: This is the cornerstone of chronic management.
    • Explain the benign nature of febrile seizures.
    • Provide clear instructions on what to do during a seizure (safety, timing).
    • Discuss the low risk of subsequent epilepsy (even with complex features, the risk is still low compared to afebrile seizures).
    • Explain the risk of recurrence and that fever control does not prevent febrile seizures.
  • Fever Management: Encourage parents to manage fever during illnesses with appropriate antipyretics to improve comfort, but emphasize it doesn't prevent seizures.
• Monitoring:
  • Regular Pediatric Follow-up: Routine well-child visits are sufficient for most children.
  • Neurology Referral: Consider for:
    • Persistent neurological concerns (e.g., unresolving Todd's paresis, developmental regression).
    • Multiple complex febrile seizures or febrile status epilepticus.
    • Atypical features suggesting an underlying seizure disorder.
    • Parental anxiety that cannot be alleviated by primary care provider.

Treatment Algorithms

• First-Line (Acute Seizure Management):
  1. Safety/ABC Management: Place child in recovery position, ensure patent airway, protect from injury.
  2. Seizure > 5 minutes: Administer benzodiazepine (rectal diazepam, intranasal/buccal midazolam, or IV lorazepam).
  3. Fever Control: Administer antipyretics.
• Second-Line (Refractory Acute Seizure/Febrile Status Epilepticus):
  1. Seizure > 15-30 minutes despite initial benzodiazepine:
     • Administer second dose of benzodiazepine.
     • Secure IV access if not already present.
     • Consider IV anticonvulsants (Fosphenytoin, Levetiracetam, Valproic Acid).
  2. Diagnostic Workup: Simultaneously initiate investigation for underlying serious causes (especially meningitis/encephalitis) if indicated by clinical red flags.
• Refractory Cases (Febrile Status Epilepticus):
  1. Continuous infusion of benzodiazepines: (e.g., midazolam infusion).
  2. Consider anesthetic agents: (e.g., propofol, phenobarbital, pentobarbital) in an ICU setting if seizures persist.
  3. Aggressive search for underlying etiology: If not yet identified.

Complications

• Common:
  • Recurrence: Approximately 30-50% of children with a simple febrile seizure will have another. For complex febrile seizures, the recurrence rate can be slightly higher. Risk factors for recurrence include: age <12 months at first seizure, lower degree of fever, shorter duration of fever before seizure, and family history of febrile seizures.
  • Parental Anxiety: A significant "complication" from a family perspective, often leading to emergency department visits, unnecessary investigations, and chronic stress.
• Serious:
  • Febrile Status Epilepticus (FSE): Febrile seizure lasting > 30 minutes. This is a medical emergency requiring prompt intervention to prevent potential neuronal injury, though long-term cognitive outcomes are often still good even after FSE.
  • Increased Risk of Subsequent Epilepsy: While the absolute risk remains low, complex febrile seizures are associated with a higher risk of developing epilepsy later in life compared to simple febrile seizures. The risk factors for developing epilepsy are:
    1. Pre-existing neurodevelopmental abnormality (e.g., cerebral palsy, developmental delay).
    2. Complex febrile seizure (especially prolonged or focal).
    3. Family history of non-febrile seizures (epilepsy). * If none of these factors are present, the risk of epilepsy is similar to the general population (around 1%). If all three are present, the risk can be as high as 49%. If one or two factors are present, the risk is intermediate (e.g., ~2-5% for complex febrile seizures without other risk factors).
• Long-term:
  • Mesial Temporal Sclerosis (MTS): While rare, prolonged febrile seizures (especially FSE) can potentially contribute to the development of MTS, which is associated with temporal lobe epilepsy. This is more of a concern in children with pre-existing vulnerability or very prolonged, refractory FSE. The exact causal relationship (whether FSE causes MTS or is a manifestation of underlying pathology predisposed to MTS) is debated.
  • Neurodevelopmental Outcomes: For the vast majority of children, even those with complex febrile seizures, neurodevelopmental outcomes are normal. If neurodevelopmental problems are identified, they usually pre-date the febrile seizures or are related to an underlying disorder rather than caused by the seizure itself.

Prognosis

• Factors:
  • Good Prognostic Factors: Normal neurodevelopment before the seizure, absence of structural brain abnormalities, absence of family history of afebrile seizures, and prompt resolution of post-ictal state.
  • Factors Affecting Recurrence: Age less than 12 months at initial seizure, lower temperature at seizure onset, short duration of fever before seizure, and a family history of febrile seizures. Complex features themselves do not directly increase recurrence risk, but are separate classification.
  • Factors Affecting Epilepsy Risk: The three major independent risk factors for subsequent epilepsy are: pre-existing neurodevelopmental abnormality, complex febrile seizure features (focal, prolonged, multiple episodes), and family history of afebrile seizures.
• Survival: Excellent. Febrile seizures are rarely fatal, with mortality almost exclusively associated with the rare underlying serious CNS infection (e.g., bacterial meningitis or encephalitis) if not diagnosed and treated promptly.
• Quality of Life: Generally unaffected. Most children with complex febrile seizures lead normal lives. The primary impact on quality of life is often parental anxiety and stress related to the seizure event and fear of recurrence. Counseling and education are essential to alleviate these concerns.

Prevention

• Primary:
  • There are no proven methods to prevent the initial occurrence of febrile seizures.
  • Routine antipyretic use during fever is not effective in preventing febrile seizures and is not recommended for this purpose. It is used for comfort.
• Secondary (Prevention of Recurrence):
  • Continuous Antiepileptic Drug (AED) Prophylaxis: Not recommended for preventing recurrence of febrile seizures or preventing subsequent epilepsy. The potential adverse effects of chronic AED use (e.g., behavioral changes, cognitive effects, idiosyncratic reactions, hepatotoxicity) outweigh the benefits of preventing usually benign febrile seizures.
  • Intermittent Oral Diazepam: Can be used at the onset of fever to reduce the risk of recurrence in children with frequent or distressing febrile seizures. However, it can cause sedation, ataxia, and behavioral changes, and does not prevent the development of epilepsy. Its use is limited to select cases.
  • Parental Education: The most important secondary prevention strategy is to educate parents about the nature of febrile seizures, recurrence risk, what to do during a seizure, and reassurance about the usually benign prognosis.
• Tertiary (Preventing Complications):
  • Prompt Treatment of Prolonged Seizures: If a febrile seizure lasts longer than 5 minutes, parents should be instructed to administer rescue benzodiazepines (if prescribed) and seek immediate medical attention to prevent febrile status epilepticus and its potential, albeit rare, long-term consequences.
  • Appropriate Diagnostic Workup: Timely and appropriate evaluation to rule out serious underlying causes (like meningitis) is crucial to prevent morbidity and mortality associated with these conditions.

Special Populations

• Pediatric: Complex febrile seizures are exclusively a pediatric condition, predominantly affecting children aged 6 months to 5 years. Management strategies and diagnostic considerations are tailored to this age group, taking into account developmental stage, difficulty in assessing neurological signs in infants, and unique susceptibility to infections.
• Comorbidities:
  • Neurodevelopmental Abnormalities: Children with pre-existing conditions such as cerebral palsy, intellectual disability, or known brain malformations are at a higher risk of experiencing complex febrile seizures. In these children, the threshold for a more extensive diagnostic workup (e.g., EEG, MRI) may be lower, as the complex features might indicate an underlying, previously unrecognized, or exacerbated neurological issue. They also have a significantly higher baseline risk of developing epilepsy.
  • Immunocompromised States: Children with compromised immune systems (e.g., chemotherapy, HIV, primary immunodeficiencies) who present with febrile seizures warrant a more aggressive workup for infection, including LP, as their risk of serious bacterial or viral CNS infections is higher and their presentation might be atypical.

Clinical Pearls

• Diagnostic:
  • Don't over-investigate: The vast majority of children with complex febrile seizures will have a benign outcome. Avoid routine LPs, EEGs, or neuroimaging unless specific red flags or clinical indications are present.
  • LP indications are key: The decision for lumbar puncture hinges on age (<12 months strong consideration, 12-18 months consideration if unvaccinated/pre-treated), and presence of meningeal signs or persistent altered mental status.
  • EEG has limited utility: A normal EEG does not rule out future epilepsy, and an abnormal EEG in an otherwise healthy child often does not warrant treatment or change prognosis. Its role is primarily in evaluating persistent atypical features or suspicion of an afebrile seizure disorder.
• Treatment:
  • Acute seizure control is paramount: Ensure safe environment and prompt administration of rescue medication if the seizure is prolonged.
  • Antipyretics for comfort, not prevention: Reassure parents that while fever reduction can make the child more comfortable, it does not reliably prevent febrile seizures.
  • Chronic AEDs are generally harmful: Avoid routine use of daily antiepileptic medications due to their side effect profiles outweighing the benefits for most children with febrile seizures.
• Pitfalls:
  • Misinterpreting post-ictal state: Distinguish between normal post-ictal drowsiness/confusion and a persistent altered mental status that might suggest CNS infection or underlying neurological issue. Todd's paresis is transient.
  • Missing meningitis: Especially in young infants where classic meningeal signs may be absent or subtle. Always maintain a high index of suspicion and consider LP as indicated.
  • Causing parental anxiety: Over-emphasizing the small risk of epilepsy or recommending unnecessary investigations can cause undue stress and negatively impact family quality of life. Provide balanced and reassuring information.

Recent Updates

• Guidelines: The American Academy of Pediatrics (AAP) reaffirmed its clinical practice guideline for the neurodiagnostic evaluation of a child with a first febrile seizure in 2021, reinforcing the limited utility of routine neuroimaging, EEG, and blood tests, while emphasizing specific indications for LP. These guidelines apply to complex febrile seizures as well, advocating for selective rather than routine workup.
• Evidence:
  • Genetics: Ongoing research continues to identify new genetic variants (e.g., in SCN1A, GABRG2) associated with increased susceptibility to febrile seizures and related conditions (e.g., Dravet Syndrome), helping to understand underlying mechanisms and refine prognosis in certain cases.
  • Neuroinflammation: Further studies are exploring the role of neuroinflammation and cytokine profiles in the pathophysiology of febrile seizures, which may inform future therapeutic strategies.
• Controversies:
  • Optimal LP indications in infants: While guidelines exist, the exact threshold for performing an LP in a child aged 6-12 months with a febrile seizure remains an area of clinical judgment and debate, especially in well-appearing children with rapid post-ictal recovery.
  • Long-term neurocognitive outcomes after FSE: While often good, specific subgroups might be at higher risk for subtle cognitive deficits. Research is ongoing to better identify these at-risk children.

Key References

• Guidelines:
  • American Academy of Pediatrics. "Neurodiagnostic Evaluation of the Child with a First Simple Febrile Seizure: Update." Pediatrics, 2011;127(2):389-394. (While focused on simple, the principles of limited workup for complex often apply in the absence of red flags).
  • American Academy of Pediatrics. "Febrile Seizures: Clinical Practice Guideline for the Long-term Management of Febrile Seizures: Update." Pediatrics, 2008;121(6):1281-1286. (Reaffirmed 2021).
• Studies:
  • Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics, 1978;61(5):720-727. (Landmark study on prognosis).
  • Shinnar S, Glauser TA. Febrile Seizures. J Child Neurol, 2002;17(suppl 1):S44-S52.
• Reviews:
  • Riviello JJ Jr, Boro A. Status Epilepticus in Children. Neurol Clin, 2005;23(4):1093-1110.
  • Pathophysiology of Febrile Seizures: Understanding the Role of Genetics and Neuroinflammation. J Child Neurol, 2018;33(1):7-18.